UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways

Cell death & disease, 2014-10, Vol.5 (10), p.e1437-e1437

2014

Volltextzugriff (PDF)

The sap from Euphorbia peplus is effective against human nonmelanoma skin cancers

British journal of dermatology (1951), 2011-03, Vol.164 (3), p.633-636

2011

Volltextzugriff (PDF)

Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy

Cancer and metastasis reviews, 2014-09, Vol.33 (2-3), p.469-496

2014

Volltextzugriff (PDF)

Detection of glypican-1 (GPC-1) expression in urine cell sediments in prostate cancer

PloS one, 2018-04, Vol.13 (4), p.e0196017-e0196017

2018

Volltextzugriff (PDF)

Longitudinal Wobbling Motion in Au 187

Physical review letters, 2020-02, Vol.124 (5), Article 052501

2020

Volltextzugriff (PDF)

In vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147

PloS one, 2012-08, Vol.7 (8), p.e40716

2012

Volltextzugriff (PDF)

Role of the EpCAM (CD326) in prostate cancer metastasis and progression

Cancer and metastasis reviews, 2012-12, Vol.31 (3-4), p.779-791

2012

Volltextzugriff (PDF)

Angiogenesis as a strategic target for prostate cancer therapy

Medicinal research reviews, 2010-01, Vol.30 (1), p.23-66

2010

Volltextzugriff (PDF)

Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance

Critical reviews in oncology/hematology, 2015-12, Vol.96 (3), p.507-517

2015

Volltextzugriff (PDF)

Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance

Cell death & disease, 2013-10, Vol.4 (10), p.e875-e875

2013

Volltextzugriff (PDF)

Longitudinal Wobbling Motion in Au187

Physical review letters, 2020-02, Vol.124 (5), p.1

2020

Volltextzugriff (PDF)

Post-translation modification of proteins in tears

Electrophoresis, 2010-06, Vol.31 (11), p.1853-1861

2010

Volltextzugriff (PDF)

Intravesical oncolytic viral therapy using attenuated, replication‐competent, herpes simplex viruses G207 and Nv1020 is effective in the treatment of bladder cancer in an orthotopic syngeneic model

The FASEB journal, 2001-05, Vol.15 (7), p.1306-1308

2001

Volltextzugriff (PDF)

CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance

The Prostate, 2014-05, Vol.74 (6), p.602-617

2014

Volltextzugriff (PDF)

Targeting uPA/uPAR in prostate cancer

Cancer treatment reviews, 2007-10, Vol.33 (6), p.521-527

2007

Volltextzugriff (PDF)

MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer

Clinical & experimental metastasis, 2005-11, Vol.22 (7), p.565-573

2005

Volltextzugriff (PDF)

The role of extracellular matrix metalloproteinase inducer protein in prostate cancer progression

Cancer Immunology, Immunotherapy, 2008-09, Vol.57 (9), p.1367-1379

2008

Volltextzugriff (PDF)

Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression

British journal of cancer, 2010-09, Vol.103 (7), p.1008-1018

2010

Volltextzugriff (PDF)

Longitudinal Wobbling Motion in ^{187}Au

Physical review letters, 2020-02, Vol.124 (5), p.052501-052501

2020

Volltextzugriff (PDF)

Absolute quantification of human tear lactoferrin using multiple reaction monitoring technique with stable-isotopic labeling

Analytical biochemistry, 2016-03, Vol.496, p.30-34

2016

Volltextzugriff (PDF)

MUC1 is a promising therapeutic target for prostate cancer therapy

Current cancer drug targets, 2007-05, Vol.7 (3), p.259-271

2007

Volltextzugriff (PDF)

CD147/EMMPRIN and CD44 are potential therapeutic targets for metastatic prostate cancer

Current cancer drug targets, 2010-05, Vol.10 (3), p.287-306

2010

Volltextzugriff (PDF)

Toxicology and Pharmacokinetics of Intravesical Gemcitabine: A Preclinical Study in Dogs

Clinical cancer research, 1999-09, Vol.5 (9), p.2629-2637

1999

Volltextzugriff (PDF)

Promising tumor-associated antigens for future prostate cancer therapy

Medicinal research reviews, 2010-01, Vol.30 (1), p.67-101

2010

Volltextzugriff (PDF)

Microarray expression profiling in melanoma reveals a BRAF mutation signature

Oncogene, 2004-05, Vol.23 (23), p.4060-4067

2004

Volltextzugriff (PDF)

1 – 25 von 957

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(880)
Mit Volltextzugriff
(777)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(596)
Life Sciences & Biomedicine
(478)
Humans
(359)
Male
(250)
Female
(223)
Biological And Medical Sciences
(184)
Animals
(173)
Adult
(147)
Medical Sciences
(130)
Middle Aged
(126)
Infectious Diseases
(122)
Physical Sciences
(103)
Immunology
(97)
Hiv
(89)
Human Immunodeficiency Virus
(80)
Hiv Infections - Drug Therapy
(78)
Fundamental And Applied Biological Sciences. Psychology
(68)
Surgery
(68)
Transplantation
(66)
Swine
(57)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways

The sap from Euphorbia peplus is effective against human nonmelanoma skin cancers

Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy

Detection of glypican-1 (GPC-1) expression in urine cell sediments in prostate cancer

Longitudinal Wobbling Motion in Au 187

In vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147

Role of the EpCAM (CD326) in prostate cancer metastasis and progression

Angiogenesis as a strategic target for prostate cancer therapy

Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance

Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance

Longitudinal Wobbling Motion in Au187

Post-translation modification of proteins in tears

Intravesical oncolytic viral therapy using attenuated, replication‐competent, herpes simplex viruses G207 and Nv1020 is effective in the treatment of bladder cancer in an orthotopic syngeneic model

CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance

Targeting uPA/uPAR in prostate cancer

MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer

The role of extracellular matrix metalloproteinase inducer protein in prostate cancer progression

Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression

Longitudinal Wobbling Motion in ^{187}Au

Absolute quantification of human tear lactoferrin using multiple reaction monitoring technique with stable-isotopic labeling

MUC1 is a promising therapeutic target for prostate cancer therapy

CD147/EMMPRIN and CD44 are potential therapeutic targets for metastatic prostate cancer

Toxicology and Pharmacokinetics of Intravesical Gemcitabine: A Preclinical Study in Dogs

Promising tumor-associated antigens for future prostate cancer therapy

Microarray expression profiling in melanoma reveals a BRAF mutation signature

Suchergebnisse filtern